In the News

A renowned vascular, heart and lung physician-scientist, Mark T. Gladwin serves as the 31st Dean of the University of Maryland School of Medicine and Vice President for Medical Affairs at the University of Maryland, Baltimore. Learn more about Dean Gladwin in a special "Chat with the Dean" podcast episode and follow him in the news below.

News Archive:

Date	Story Topic
09/11/25	Scientific American spoke with Dean Mark Gladwin, MD, about his research on developing a rapid antidote to carbon monoxide poisoning using engineered protein therapy.
08/18/25	Dean Mark Gladwin, MD discusses cutting edge treatments for Sickle Cell Disease with former Secretary of Maryland’s Health Department, Josh Sharfstein, MD, on the Public Health On Call podcast.
08/13/25	A new study by Dean Mark Gladwin, MD, and Jason Rose, MD, MBA (Medicine) on a promising antidote for carbon monoxide poisoning is highlighted in media and science publications.
06/12/25	Dean Mark Gladwin, MD, is quoted in coverage of a new $2.4 million investment in UMSOM's Rural-MD scholars initiative.
05/22/25	Dean Mark Gladwin's remarks about the importance of federally-funded research at UMSOM graduation are featured alongside those of leading vaccine expert and commencement speaker Paul Offit.
05/09/25	Dean Mark Gladwin, MD, (Medicine) is interviewed about cuts to federal research funding.
04/04/2025	Dean Mark Gladwin, MD, and Wilbur Chen, MD, MS, (Medicine, Center for Vaccine Development and Global Health, CVD) are quoted on the importance of federal research funding.
02/03/25	Dean Mark Gladwin, MD and Allan Doctor, MD, (Pediatrics) are quoted in an article about ongoing research efforts to develop artificial blood.
01/08/25	Dean Mark Gladwin, MD, Bartley Griffith, MD, Muhammad Mohiuddin, MBBS, and Christine Lau, MD, MBA (Surgery), discuss insights from the xenotransplantation case of Larry Faucette.

2024

Date	Story Topic
09/17/24	Dean Mark Gladwin, MD, (Medicine) is quoted in an article about advancements in sickle cell disease therapies.
08/30/24	Dean Mark Gladwin's appointment of Elana Fertig, PhD, to be the new director of the Institute of Genome Sciences received widespread media coverage.
08/21/24	Dean Mark Gladwin, MD, and Taofeek Owonikoko, MBChB, DrMed, MS, (Medicine) discuss a partnership with Lagos University Teaching Hospital to improve the management of chronic diseases.
08/13/24	Dean Mark Gladwin, MD and Taofeek Owonikoko, MBChB, DrMed, MS, (Medicine) are highlighted in coverage of the Institute of Human Virology Nigeria's (IHVN) symposium.
07/12/24	Dean Mark Gladwin, MD, and Kathryn Hughes Barry, PhD, MPH, (Epidemiology and Public Health) are quoted on a study linking the stress of living in disadvantaged neighborhoods to higher rates of aggressive prostate cancer in African-American men.
07/09/24	Dean Mark Gladwin, MD, Esa Davis, MD, MPH (Family and Community Medicine), Rachel Hoover, MS, MBA, and William Regine, MD, FACR, FACRO (Radiation Oncology) discuss the new "health village" coming to Mondawmin Mall.
04/30/24	Dean Mark Gladwin, MD is named a Power Player in Health Care by The Daily Record
04/25/24	Dean Mark Gladwin, MD, is quoted on plans to establish a for-profit entity and expand UM network of primary care doctors.
04/16/24	Dean Mark Gladwin, MD, and Taofeek Owonikoko, MBChB, DrMed, MS, discuss the University of Maryland Greenbaum Comprehensive Cancer Center and AstraZeneca partnership to increase lung cancer screenings.
04/11/24	Dean Mark Gladwin's, MD, study finding Riociguat may be effective in managing complications from sickle cell disease is shared by several outlets.
03/18/24	Dean Mark Gladwin, MD,  and Institute of Human Virology (IHV) faculty, Mohammed Sajadi, MD, George Lewis, PhD, Shyamasundaran Kotillil, MBBD, PHD, discuss new study on COVID-19 antibody response durability.
03/15/24	UMSOM Dean Mark Gladwin, MD, discusses sickle cell disease and the red cell exchange transfusion trial, SCD-CARRE.
03/12/24	Dean Mark Gladwin, MD, Rozalina McCoy, MD, MS (Medicine), and Esa Davis, MD (Family & Community Medicine), are quoted on new study finding people in rural towns have higher risk of diabetes-related complications.
02/28/24	Dean Mark Gladwin, MD, is featured in a piece discussing a new program that will bring medical students to the Eastern Shore to improve rural access to healthcare.
01/25/24	Dean Mark Gladwin, MD, and  Kathleen Neuzil, MD, MPH, FIDSA (Medicine) are quoted on clinical trial finding a single-dose of the typhoid conjugate vaccine can protect kids long-term.

2023

Date	Story Topic
10/17/23	Dean Mark Gladwin, MD, discusses the how artificial intelligence will revolutionize healthcare and what we need to do to prepare.
09/22/23	UMSOM's Dean Gladwin is quoted on new Center for Violence Prevention established by UMB.
09/15/23	A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
09/14/23	A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
09/14/23	A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
09/14/23	A new study by UMSOM Dean Mark Gladwin, MD, and Anthony DeMartino, PhD (Medicine) on nitric oxide and its potential for therapeutic uses is featured in media and science publications.
06/15/23	UMSOM Dean Mark Gladwin and Dr. Sarah Kattakuzhy are quoted in this article about the new Kahlert Institute for Addiction Medicine.
06/01/23	UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
05/31/23	UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
05/31/23	UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
05/31/23	UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
05/31/23	UMSOM's Dean Mark Gladwin, Dr. Eric Weintraub, and Dr. Sarah Kattakuzhy were quoted on press announcement of new Kahlert Institute for Addiction Medicine.
02/01/23	UMSOM's Dr. Allan Doctor and Dean Mark Gladwin are quoted on new $46 million in federal funding to develop artificial blood product.
01/29/23	UMSOM Dean Mark Gladwin discusses the new University of Maryland-3 Institute for Health Computing and future plans.
01/28/23	UMSOM Dean Mark T. Gladwin discusses a new CVD-led study investigating an antimalarial monoclonal antibody.
01/27/23	UMSOM Dean Mark T. Gladwin comments on a new CVD-led challenge study of a monoclonal antibody for malaria.
01/10/23	UMSOM's Dean Gladwin announces hiring of new chief philanthropy officer Heather Culp.
01/10/23	UMSOM's Dean Gladwin announces hiring of new chief philanthropy officer Heather Culp.

2022

Date	Story Topic
12/30/22	UMSOM's Dean Mark Gladwin provides information on the new Institute for Health Computing and efforts to spur investing in bio health innovation in Maryland.
11/11/22	UMSOM's Dean Gladwin was quoted on the announcement of a new Institute of Health Computing that will be located in Montgomery County.
11/10/22	UMSOM's Dean Gladwin discusses the new University of Maryland Institute of Health Computing.
10/18/22	UMSOM's Dean Mark Gladwin profiled in featured mover discussing his career, goals and hobbies.
10/17/22	UMSOM's Dean Mark Gladwin is quoted on plans to open a new brain research institute across UMB to better understand how the brain develops and factors that lead to brain diseases like Alzheimer's.